SCHEMBL27056141

SCHEMBL27056141

C1=CC2Sc3ccccc3N(CCCN3CCCC3)C2C=C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 11/20 0.39
▸ FPR2 P25090 2/20 0.38
▸ BCHE P06276 2/20 0.35
▸ HRH3 Q9Y5N1 2/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ CHRM4 P08173 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ CHRM5 P08912 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ CHRM3 P20309 1/20 0.35
▸ DRD1 P21728 1/20 0.35
▸ HRH2 P25021 1/20 0.35
▸ HTR1B P28222 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HRH1 P35367 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21319396 0.79 CYP2D6 (0.48) KDM1ACHRM2CHRM4HTR1ACHRM5
SCHEMBL15305673 0.77 — —
SCHEMBL18779843 0.77 MAPT (0.37) —
SCHEMBL27056130 0.77 POLB (0.38) KDM1ABCHEHRH3CHRM2CHRM4
SCHEMBL15304786 0.77 — —
SCHEMBL27056167 0.76 ADRA2A (0.43) HRH3CHRM2CHRM4HTR1ACHRM5
SCHEMBL19759877 0.76 ALDH1A1 (0.33) KDM1A
SCHEMBL15362393 0.74 KDM1A (0.46) KDM1AFPR2HRH3CHRM2CHRM4
SCHEMBL15362392 0.73 DRD2 (0.45) KDM1AHRH3CHRM2CHRM4HTR1A
SCHEMBL15362396 0.72 LMNA (0.45) KDM1AFPR2HRH3CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3473254-B1 PHENOTHIAZINE DERIVATIVES FOR THE TREATMENT OF AUTOIMMUNE DISEASES HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH (DE) 2024-01-24 — — EP disclosed
Send feedback